FSSAI suspends licences of 6 nutraceutical firms over safety violations

Share:
Audio Loading voice…
FSSAI suspends licences of 6 nutraceutical firms over safety violations

Synopsis

FSSAI has suspended licences of six nutraceutical manufacturers after inspections uncovered a sweeping range of violations — from a vitamin E capsule that contained wheat germ oil instead, to probiotic products harbouring pathogenic microbial strains. The action is one of the most publicly detailed enforcement rounds in the sector and raises hard questions about how safely India's booming wellness supplement market is actually regulated.

Key Takeaways

FSSAI announced licence suspensions and regulatory action against six nutraceutical firms on 16 November 2026 .
The named companies are Airen Herbals , Aquabliss Lifesciences , Raskam Healthcare , Supercure Biotech , Ambico Ayurvedic Healthcare , and Vedant Remedies .
Supercure Biotech's vitamin E softgel capsule was found to contain wheat germ oil instead of vitamin E, and its probiotic products tested positive for pathogenic microbial strains .
Airen Herbals' 'Lycowey Syrup' contained multiple nutrients — including copper, selenium, and zinc — above prescribed RDA limits .
Multiple firms, including Aquabliss Lifesciences , Ambico Ayurvedic Healthcare , and Vedant Remedies , were found using expired raw materials in manufacturing.
FSSAI has stated it will continue intensified inspections of nutraceutical manufacturing facilities.

The Food Safety and Standards Authority of India (FSSAI) on Monday, 16 November 2026, announced regulatory action against six nutraceutical manufacturers, including suspension of licences, following the detection of serious food safety and compliance violations during recent facility inspections. The crackdown signals an intensifying scrutiny of India's fast-growing nutraceutical sector — a category of food-derived products marketed for specific health benefits beyond basic nutrition.

Companies Facing Action

The six firms named by FSSAI are Airen Herbals, Aquabliss Lifesciences, Raskam Healthcare, Supercure Biotech, Ambico Ayurvedic Healthcare, and Vedant Remedies. Inspectors identified violations ranging from excess nutrient levels and mislabelling to the use of expired raw materials and the presence of pathogenic microbial strains.

Key Violations Found

At Airen Herbals, the product 'Lycowey Syrup' was found to contain thiamin, vitamin E acetate, copper, selenium, and zinc at levels exceeding prescribed Recommended Dietary Allowance (RDA) limits per serving. A second product, 'Maxford Pain Relief', was flagged for making unauthorised claims related to knee relief, using imagery associated with pain relief, and non-compliance in botanical ingredient declarations.

Aquabliss Lifesciences was cited for storing expired raw materials at its manufacturing site alongside poor sanitation and hygiene standards. Raskam Healthcare was found using Shilajit — an ingredient not approved for the identified products — along with deficiencies in record-keeping and documentation.

Inspections at Supercure Biotech revealed multiple irregularities: its 'Gemkolin 9G softgel capsules' contained biotin levels exceeding the maximum permitted limit; a product marketed as a vitamin E softgel capsule was found to contain wheat germ oil instead of vitamin E — a substitution authorities said could mislead consumers. The company was also flagged for labelling deficiencies and the presence of non-permitted and pathogenic microbial strains in its probiotic products.

Ambico Ayurvedic Healthcare was found using expired materials in nutraceutical preparations while maintaining inadequate hygiene standards at its manufacturing premises. Vedant Remedies was cited for the use of expired materials in flavouring products, sanitation shortcomings, housekeeping deficiencies, and inadequate manufacturing infrastructure and testing facilities.

Why This Matters

India's nutraceutical industry has expanded rapidly in recent years, riding post-pandemic demand for immunity and wellness products. However, the sector has long faced concerns about inconsistent regulation, with critics arguing that enforcement has lagged behind market growth. This is among the most comprehensive enforcement actions FSSAI has publicly disclosed against nutraceutical firms, covering a broad sweep of violations — from product formulation and labelling to hygiene and testing infrastructure. Consumers relying on these products for specific health outcomes face the risk of either ineffective formulations or, in some cases, potentially harmful ones.

What Happens Next

FSSAI has stated that it has intensified inspections of manufacturing facilities in recent months and will continue to identify instances of non-compliance. The affected companies are expected to face formal proceedings, and licence reinstatement would typically require demonstrated corrective action. Industry associations are likely to face pressure to adopt stronger self-regulatory frameworks in the wake of the action.

Point of View

And pathogens in probiotic capsules, are consumer safety failures of the first order. India's nutraceutical sector has grown largely in a regulatory grey zone: not quite a drug, not quite a food, and historically policed with neither rigour. FSSAI's decision to publicly name companies is a meaningful step, but suspension alone does not address the structural gap — there is no mandatory pre-market efficacy or safety review for nutraceuticals, which means violations are only caught post-launch, often after products have already reached consumers. The harder question mainstream coverage is not asking is how many more such products are on shelves that have not yet been inspected.
NationPress
16 Nov 2026

Frequently Asked Questions

Which companies has FSSAI taken action against?
FSSAI has taken regulatory action, including licence suspension, against six nutraceutical firms: Airen Herbals, Aquabliss Lifesciences, Raskam Healthcare, Supercure Biotech, Ambico Ayurvedic Healthcare, and Vedant Remedies. The action follows inspections that uncovered violations including mislabelling, expired raw materials, and pathogenic microbial contamination.
What violations were found in Supercure Biotech's products?
Supercure Biotech's 'Gemkolin 9G softgel capsules' were found to contain biotin above the maximum permitted level. A product marketed as a vitamin E softgel capsule was found to contain wheat germ oil instead of vitamin E. Its probiotic products also tested positive for non-permitted and pathogenic microbial strains.
Why is FSSAI cracking down on nutraceutical companies?
FSSAI has intensified inspections of the nutraceutical sector amid heightened scrutiny of a rapidly growing industry where non-compliance relating to formulations, labelling, hygiene, and manufacturing practices has been repeatedly identified. The authority says the action follows detection of significant safety and regulatory violations during recent inspections.
What are nutraceuticals and why do they matter to consumers?
Nutraceuticals are food-derived products marketed for specific health benefits beyond basic nutrition — such as vitamins, minerals, herbal supplements, and probiotics. Consumers often use them for immunity, wellness, or therapeutic purposes, making accurate labelling and safe formulation critical to avoid harm.
What happens to companies whose licences are suspended by FSSAI?
Companies with suspended licences are typically required to halt production and demonstrate corrective action before reinstatement. FSSAI can also initiate formal legal proceedings under the Food Safety and Standards Act. The duration of suspension and further penalties depend on the nature and severity of violations found.
Nation Press
The Trail

Connected Dots

Tracing the thread behind this story — newest first.

8 Dots
  1. Latest 4 weeks ago
  2. 1 month ago
  3. 3 months ago
  4. 3 months ago
  5. 3 months ago
  6. 3 months ago
  7. 3 months ago
  8. 5 months ago
Google Prefer NP
On Google